Breast cancer scientist. Asst Prof @CUAnschutz. Studying endocrine rx response & resistance, focus on #lobular BrCa. Tweets are my own. He/Him. Lab: @SikoraLab
In this trial, patients will be treated before surgery for 21 days with tamoxifen, anastrozole, or fulvestrant (all current drugs that target the estrogen receptor).
You might say, it's a short treatment without any new fancy drugs. What's important about this trial? 2/